ScholarIQanswers from OpenAlex

Faricimab Treat-and-Extend for Diabetic Macular Edema

PaperCitations, authors & open-access status

Faricimab Treat-and-Extend for Diabetic Macular Edema is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Faricimab Treat-and-Extend for Diabetic Macular Edema have?

ScholarIQcitation count

Faricimab Treat-and-Extend for Diabetic Macular Edema has 151 citations in the OpenAlex counts ScholarIQ stores.

When was Faricimab Treat-and-Extend for Diabetic Macular Edema published?

ScholarIQyear

Faricimab Treat-and-Extend for Diabetic Macular Edema has 2023 year in the ScholarIQ index.

What is the open-access status of Faricimab Treat-and-Extend for Diabetic Macular Edema?

ScholarIQoa status

Faricimab Treat-and-Extend for Diabetic Macular Edema has hybrid oa status in the ScholarIQ index.

What is the DOI of Faricimab Treat-and-Extend for Diabetic Macular Edema?

ScholarIQdoi

The DOI for Faricimab Treat-and-Extend for Diabetic Macular Edema is on the source record.

What is the PMID of Faricimab Treat-and-Extend for Diabetic Macular Edema?

ScholarIQpmid

The PMID for Faricimab Treat-and-Extend for Diabetic Macular Edema is on the source record.

What is the OpenAlex record for Faricimab Treat-and-Extend for Diabetic Macular Edema?

ScholarIQopenalex

The OpenAlex for Faricimab Treat-and-Extend for Diabetic Macular Edema is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial